The carbamoyl phosphate instead goes into the uridine monophosphate synthetic pathway.

The role of cyclic uridine monophosphate (cUMP) is even less well known.

Uridine monophosphate is a major component of RNA.

Uridine phosphorylase adds ribose-1-phosphate to the free base uracil, forming uridine monophosphate.

Orotidine-5-phosphate is decarboxylated by orotidine-5'-phosphate decarboxylase to form uridine monophosphate (UMP).

Administration of cytidine monophosphate and uridine monophosphate reduces urinary orotic acid and the anemia.

In brain research studies such as those mentioned in this article, uridine monophosphate is used as a convenient delivery compound for uridine.

These two sites catalyze the last two steps of the de novo uridine monophosphate (UMP) biosynthetic pathway.

Uridine monophosphate is formed from Orotidine 5'-monophosphate (orotidylic acid) in a decarboxylation reaction catalyzed by the enzyme orotidylate decarboxylase.

In microorganisms, these two domains are separate proteins, but in multicellular eukaryotes, the two catalytic sites are expressed on a single protein, uridine monophosphate synthetase.

It catalyzes the decarboxylation of orotidine monophosphate (OMP) to form uridine monophosphate (UMP).

Orotidine 5'-monophosphate (OMP), also known as orotidylic acid, is a pyrimidine nucleotide which is the last intermediate in the biosynthesis of uridine monophosphate.

Uridine monophosphate, also known as 5'-uridylic acid and abbreviated UMP, is a nucleotide that is used as a monomer in RNA.

Nucleic acid aptamers, including Spiegelmers, contain adenosine monophosphate, guanosine monophosphate, cytidine monophosphate, uridine monophosphate, a phosphate group, a nucleobase and a ribose sugar.

Other names in common use include uridylate kinase, UMPK, uridine monophosphate kinase, PyrH, UMP-kinase, and SmbA.

This process is initiated by the covalent attachment of Uridine monophosphate (UMP) to the terminal protein VPg, yielding VPgpU and VPgpUpU.

It is activated by ATP and PRPP and it is inhibited by UMP (Uridine monophosphate, the end product of the pyrimidine synthesis pathway).

After addition of ribose-P to orotate by OPRTase to form orotidine-5'-monophosphate (OMP), OMP is decarboxylated to form uridine monophosphate by ODCase.

In a study, gerbils fed a combination of uridine monophosphate, choline, and docosahexaenoic acid (DHA) were found to have significantly improved performance in running mazes over those not fed the supplements, implying an increase in cognitive function.

Many studies investigated the binding of a potent inhibitor of OMP decarboxylase, 6-hydroxy uridine monophosphate (BMP, a barbituric acid derivative), within the active site, to identify which essential amino acid residues are directly involved with stabilization of the transition state.